---
figid: PMC5422478__fimmu-08-00521-g004
figtitle: Autoantibodies in the pathogenesis of Graves’ orbitopathy
organisms:
- NA
pmcid: PMC5422478
filename: fimmu-08-00521-g004.jpg
figlink: /pmc/articles/PMC5422478/figure/F4/
number: F4
caption: 'Autoantibodies in the pathogenesis of Graves’ orbitopathy. Anti-TSHR antibodies
  bind to the TSHR on orbital fibroblasts, which initiate signaling through Gαs and
  Gαq subunits. The Gαs complex initiates signaling by the protein kinase A through
  generation of cAMP by adenylyl kinase (AC). The Gαq pathway mediates activation
  of phospholipase C (PLC) and leads to activation of phosphatidylinositol 3,4,5 triphosphate
  by phosphatidylinositol 3,4,5 triphosphate kinase (PI3K) under the influence of
  insulin receptor substrate 1 (IRS-1). Akt activation results in mammalian target
  of rapamycin (mTOR) signaling with proliferation and secretion of cytokines, hyaluronic
  acid, and adipogenesis. Activation of orbital fibroblasts by T cells occurs via
  binding of the CD154 molecule on the T cell surface to the CD40 on the fibroblast
  surface. Abbreviations: IGF-1, insulin growth factor 1; IGF-1R, insulin growth factor
  1 receptor; MCP-1, monocyte chemotactic protein 1; TNF-α, tumor necrosis factor-alpha;
  TSHR, thyroid-stimulating hormone receptor.'
papertitle: 'Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and
  Extra-Thyroidal Diseases.'
reftext: Eleonore Fröhlich, et al. Front Immunol. 2017;8:521.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.698119
figid_alias: PMC5422478__F4
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5422478__F4
ndex: 3eb63713-de8f-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5422478__fimmu-08-00521-g004.html
  '@type': Dataset
  description: 'Autoantibodies in the pathogenesis of Graves’ orbitopathy. Anti-TSHR
    antibodies bind to the TSHR on orbital fibroblasts, which initiate signaling through
    Gαs and Gαq subunits. The Gαs complex initiates signaling by the protein kinase
    A through generation of cAMP by adenylyl kinase (AC). The Gαq pathway mediates
    activation of phospholipase C (PLC) and leads to activation of phosphatidylinositol
    3,4,5 triphosphate by phosphatidylinositol 3,4,5 triphosphate kinase (PI3K) under
    the influence of insulin receptor substrate 1 (IRS-1). Akt activation results
    in mammalian target of rapamycin (mTOR) signaling with proliferation and secretion
    of cytokines, hyaluronic acid, and adipogenesis. Activation of orbital fibroblasts
    by T cells occurs via binding of the CD154 molecule on the T cell surface to the
    CD40 on the fibroblast surface. Abbreviations: IGF-1, insulin growth factor 1;
    IGF-1R, insulin growth factor 1 receptor; MCP-1, monocyte chemotactic protein
    1; TNF-α, tumor necrosis factor-alpha; TSHR, thyroid-stimulating hormone receptor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1
  - APP
  - SUCLA2
  - IGF1R
  - GNAQ
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - TSHR
  - GAST
  - GALNS
  - PAGR1
  - CD40
  - IL1B
  - IL6
  - IL10
  - TNF
  - CCL2
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - IRS1
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - Prostaglandin E2
---
